## Core Concept
Tacrolimus is a calcineurin inhibitor used as an immunosuppressant to prevent organ rejection in transplant patients. It has a narrow therapeutic index, and its levels can be influenced by various drug interactions. Understanding these interactions is crucial for managing patients on tacrolimus therapy.

## Why the Correct Answer is Right
Rifampicin is known to induce the cytochrome P450 3A4 enzyme, which is responsible for metabolizing tacrolimus. By inducing this enzyme, rifampicin increases the metabolism of tacrolimus, thereby decreasing its blood levels and reducing the risk of toxicity. This is in contrast to the other options listed, which either inhibit the cytochrome P450 system or have other mechanisms that can lead to increased tacrolimus levels and toxicity.

## Why Each Wrong Option is Incorrect
* **Option A:** Ketoconazole is an antifungal that inhibits the cytochrome P450 3A4 enzyme. By inhibiting this enzyme, ketoconazole decreases the metabolism of tacrolimus, leading to increased levels and potentially precipitating toxicity.
* **Option B:** Erythromycin is a macrolide antibiotic that also inhibits the cytochrome P450 3A4 enzyme. Similar to ketoconazole, it can decrease the metabolism of tacrolimus, increasing its levels and the risk of toxicity.
* **Option D:** Ciprofloxacin is a fluoroquinolone antibiotic that can also interact with tacrolimus, although its mechanism may be less direct. It can still contribute to increased levels of tacrolimus, potentially leading to toxicity.

## Clinical Pearl / High-Yield Fact
A key point to remember is that drug interactions with tacrolimus can significantly impact its therapeutic levels. When co-administering drugs that may interact with tacrolimus, it's essential to monitor tacrolimus levels closely and adjust doses as necessary to prevent toxicity or underimmunosuppression.

## Correct Answer Line
**Correct Answer: C. Rifampicin**